1. World Health Organization. Global tuberculosis report 2019, WHO report 2019. Geneva: World Health Organization; 2020. p. 283.
2. Bourinbaiar AS, Batbold U, Efremenko Y, et al. Phase III, placebo-controlled, randomized, double-blind trial of tableted, therapeutic TB vaccine (V7) containing heat-killed M. vaccae administered daily for one month. J Clin Tuberc Other Mycobact Dis. 2020;18:1–8.
3. Butov D, Feshchenko Y, Kuzhko M, et al. Effectiveness of Intravenous Isoniazid and Ethambutol Administration in Patients with Tuberculosis Meningoencephalitis and HIV Infection. Tuberc Respir Dis. 2020;83(1):96–103.
4. World Health Organization. People-centred frame work for tuberculosis programme planning and prioritization, Userguide. Geneva: World Health Organization; 2019. p. 64.
5. WHO, editor. WHO Guidelines on tuberculosis infection prevention and control. Geneva: World Health Organization; 2019. p. 52.